Allogene Therapeutics (ALLO) stock Forecast for 2022, 2023, 2024, 2025

The forecast has been updated: January 29, 2023 12:51


Allogene Therapeutics stock price online today

Analyst Target Price

22.53

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Allogene Therapeutics stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2022, 2024, 2025?

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $22.53 target price for Allogene Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (10.33 $).

50 Day Moving Average is the resistance level (7.95 $).




Allogene Therapeutics stock monthly Forecast

Date Rate Forecast MIN Rate MAX Rate Volati-
lity, %
31 Jan 23 9.80 9.44 10.04 6.40 %
01 Feb 23 9.70 9.29 9.94 7.01 %
02 Feb 23 9.34 8.85 9.69 9.46 %
03 Feb 23 9.03 8.87 9.49 7.06 %
04 Feb 23 9.62 9.15 9.89 8.10 %
05 Feb 23 9.81 9.47 10.31 8.92 %
06 Feb 23 10.04 9.80 10.60 8.10 %
07 Feb 23 10.27 10.12 10.45 3.27 %
08 Feb 23 10.94 10.66 11.14 4.52 %
09 Feb 23 11.04 10.80 11.37 5.29 %
10 Feb 23 11.13 10.50 11.43 8.82 %
11 Feb 23 11.51 10.92 12.07 10.48 %
12 Feb 23 11.26 10.78 11.62 7.82 %
13 Feb 23 11.73 11.23 12.00 6.87 %
14 Feb 23 12.17 11.73 12.83 9.44 %
15 Feb 23 11.96 11.56 12.51 8.18 %
16 Feb 23 12.43 11.88 12.88 8.43 %
17 Feb 23 13.15 12.78 13.50 5.62 %
18 Feb 23 12.55 11.90 13.02 9.45 %
19 Feb 23 12.40 11.70 13.01 11.12 %
20 Feb 23 12.28 11.98 12.92 7.89 %
21 Feb 23 12.03 11.43 12.61 10.31 %
22 Feb 23 12.34 11.99 12.58 4.90 %
23 Feb 23 12.88 12.69 13.34 5.11 %
24 Feb 23 13.55 13.31 13.82 3.78 %
25 Feb 23 13.08 12.72 13.33 4.82 %
26 Feb 23 13.05 12.82 13.52 5.49 %
27 Feb 23 12.30 11.71 12.71 8.61 %
28 Feb 23 11.76 11.59 12.26 5.75 %
01 Mar 23 11.85 11.65 12.44 6.76 %

ALLO daily forecast for this month


Allogene Therapeutics stock forecast for 31.01.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.80 Positive intraday dynamics of the instrument is expected with 6.013% volatility is expected.

Pessimistic forecast: 9.44

Optimistic: 10.04


Allogene Therapeutics stock forecast for 01.02.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.70 Negative intraday dynamics of the instrument is expected with 6.555% volatility is expected.

Pessimistic forecast: 9.29

Optimistic: 9.94


Allogene Therapeutics stock forecast for 02.02.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.34 Negative intraday dynamics of the instrument is expected with 8.639% volatility is expected.

Pessimistic forecast: 8.85

Optimistic: 9.69


Allogene Therapeutics stock forecast for 03.02.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.03 Negative intraday dynamics of the instrument is expected with 6.593% volatility is expected.

Pessimistic forecast: 8.87

Optimistic: 9.49


Allogene Therapeutics stock forecast for 04.02.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 9.62 Positive intraday dynamics of the instrument is expected with 7.490% volatility is expected.

Pessimistic forecast: 9.15

Optimistic: 9.89


ALLO Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Feb 9.66 8.98 10.05 10.66 %
Mar 9.86 9.21 10.26 10.28 %
Apr 9.90 9.50 10.60 10.36 %
May 9.66 9.36 10.36 9.61 %
Jun 9.53 9.32 9.73 4.21 %
Jul 9.36 8.98 9.72 7.60 %
Aug 9.14 8.67 9.84 11.88 %
Sep 8.98 8.60 9.43 8.86 %
Oct 8.91 8.63 9.56 9.79 %
Nov 9.56 8.96 9.94 9.82 %
Dec 9.16 8.45 9.49 11.00 %

Allogene Therapeutics stock forecast for this year


Allogene Therapeutics share price average forecast for Feb 2023 is: 9.65756 The dynamics are positive.
Allogene Therapeutics share price average forecast for Mar 2023 is: 9.86037 The dynamics are positive.
Allogene Therapeutics share price average forecast for Apr 2023 is: 9.89981 The dynamics are positive.
Allogene Therapeutics share price average forecast for May 2023 is: 9.66222 The dynamics are negative.
Allogene Therapeutics share price average forecast for Jun 2023 is: 9.52694 The dynamics are negative.
Allogene Therapeutics share price average forecast for Jul 2023 is: 9.35546 The dynamics are negative.
Allogene Therapeutics share price average forecast for Aug 2023 is: 9.14028 The dynamics are negative.
Allogene Therapeutics share price average forecast for Sep 2023 is: 8.9849 The dynamics are negative.
Allogene Therapeutics share price average forecast for Oct 2023 is: 8.91302 The dynamics are negative.
Allogene Therapeutics share price average forecast for Nov 2023 is: 9.56367 The dynamics are positive.
Allogene Therapeutics share price average forecast for Dec 2023 is: 9.162 The dynamics are negative.


Allogene Therapeutics stock Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 9.46 9.09 9.68 6.16 %
Feb 9.13 8.41 9.43 10.84 %
Mar 9.82 9.62 10.60 9.26 %
Apr 9.72 9.07 10.47 13.37 %
May 9.37 9.09 9.56 4.90 %
Jun 9.34 9.11 9.93 8.28 %
Jul 10.20 9.75 10.92 10.65 %
Aug 10.17 9.91 10.80 8.29 %
Sep 10.56 9.87 11.14 11.37 %
Oct 10.41 9.84 10.71 8.16 %
Nov 10.61 10.30 11.33 9.08 %
Dec 10.62 9.85 10.99 10.34 %

Allogene Therapeutics stock Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 10.24 9.63 10.90 11.64 %
Feb 11.02 10.35 11.48 9.80 %
Mar 11.97 11.23 12.85 12.58 %
Apr 13.14 12.09 13.92 13.13 %
May 12.55 11.81 12.85 8.11 %
Jun 12.24 11.40 13.05 12.66 %
Jul 12.61 11.67 13.04 10.44 %
Aug 11.41 10.92 12.05 9.38 %
Sep 11.47 10.85 12.26 11.51 %
Oct 11.48 10.80 12.17 11.23 %
Nov 11.65 10.93 12.55 12.91 %
Dec 12.44 11.76 13.42 12.42 %



Allogene Therapeutics stock Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 12.50 12.00 12.75 5.88 %
Feb 12.53 12.02 13.43 10.54 %
Mar 13.31 12.89 13.83 6.74 %
Apr 14.25 13.24 15.02 11.86 %
May 13.25 12.66 13.52 6.37 %
Jun 13.19 12.15 13.56 10.41 %
Jul 13.85 12.88 14.16 9.09 %
Aug 13.56 13.24 14.18 6.60 %
Sep 13.30 12.34 13.62 9.37 %
Oct 13.10 12.31 13.36 7.84 %
Nov 14.24 13.53 15.25 11.30 %
Dec 13.97 13.26 14.67 9.62 %

Allogene Therapeutics stock Forecast for 2027

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 14.37 13.61 15.38 11.50 %
Feb 14.49 13.36 15.14 11.77 %
Mar 14.14 13.69 15.10 9.36 %
Apr 15.43 14.62 15.95 8.32 %
May 15.86 14.76 16.86 12.42 %
Jun 15.89 15.45 16.92 8.73 %
Jul 14.52 13.67 15.25 10.38 %
Aug 13.96 13.47 14.36 6.22 %
Sep 13.83 13.33 14.88 10.41 %
Oct 13.89 13.54 14.58 7.14 %
Nov 15.11 14.28 15.83 9.83 %
Dec 16.36 15.35 17.07 10.07 %

Allogene Therapeutics overview

Allogene Therapeutics Address

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Market Capitalization

944 576 000 $

EBITDA

-297 499 008

PE Ratio

None

PEG Ratio

None

Dividend Per Share

0

Dividend Yield

0

EPS

-2.2

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

-

Forward PE

-

EV To Revenue

2674.75

EV To EBITDA

-2.221

52 Week High

17.49

52 Week Low

5.41

50 Day Moving Average

7.95

200 Day Moving Average

10.33

Shares Outstanding

144210000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 98.07 (04.11.2022) 1.68 %
AbbVie Inc.
ABBV 145.28 (04.11.2022) 0.60 %
Aeterna Zentaris Inc.
AEZS 4.01 (04.11.2022) 2.82 %
Allakos Inc.
ALLK 5.99 (04.11.2022) 5.83 %
Allogene Therapeutics, Inc.
ALLO 9.34 (04.11.2022) -1.89 %
Amgen Inc.
AMGN 269.04 (04.11.2022) 1.19 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 4.75 (04.11.2022) 2.15 %
Aurora Cannabis Inc.
ACB 1.31 (04.11.2022) -5.07 %
Becton Dickinson and Company
BDX 220.84 (04.11.2022) -0.07 %
Biogen Inc.
BIIB 281.82 (04.11.2022) 0.56 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 15.47 (04.11.2022) 4.60 %
BioNTech SE
BNTX 154.31 (04.11.2022) 6.24 %
bluebird bio, Inc.
BLUE 6.13 (04.11.2022) -2.23 %
Boston Scientific Corp.
BSX 41.59 (04.11.2022) 0.14 %
Bristol-Myers Squibb Company
BMY 78.78 (04.11.2022) 0.38 %
Canopy Growth Corp.
CGC 3.29 (04.11.2022) -4.64 %
Castle Biosciences, Inc.
CSTL 21.94 (04.11.2022) -9.60 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 19.96 (04.11.2022) 2.20 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 8.32 (04.11.2022) 4.92 %
Gilead Sciences, Inc.
GILD 80.34 (04.11.2022) 1.11 %
GlaxoSmithKline plc
GSK 32.99 (04.11.2022) 0.46 %
GoodRx Holdings, Inc.
GDRX 5.06 (04.11.2022) 3.27 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 77.3 (04.11.2022) 0.52 %
Inovio Pharmaceuticals, Inc.
INO 2.11 (04.11.2022) -1.40 %
Johnson & Johnson
JNJ 171.48 (04.11.2022) 0.45 %
Medtronic plc.
MDT 84.65 (04.11.2022) 0.75 %
Merck & Co., Inc.
MRK 99.2 (04.11.2022) 0.46 %
Moderna, Inc.
MRNA 158.41 (04.11.2022) 7.40 %
Novartis AG
NVS 81.72 (04.11.2022) 1.67 %
Novavax, Inc.
NVAX 19.4 (04.11.2022) -3.82 %
ObsEva SA
OBSV 0.1688 (04.11.2022) 0.60 %
OrganiGram Holdings Inc.
OGI 0.9738 (04.11.2022) 0.11 %
Pfizer Inc.
PFE 47.22 (04.11.2022) 1.40 %
Regeneron Pharmaceuticals, Inc.
REGN 740.21 (04.11.2022) 0.21 %
Sanofi
SNY 43.62 (04.11.2022) 1.82 %
Schrodinger, Inc.
SDGR 20.92 (04.11.2022) -15.17 %
Senseonics Holdings, Inc.
SENS 1.18 (04.11.2022) -0.84 %
Sorrento Therapeutics, Inc.
SRNE 1.46 (04.11.2022) -1.35 %
Stryker Corp.
SYK 210.98 (04.11.2022) 2.66 %
Sundial Growers Inc.
SNDL 2.32 (04.11.2022) -2.52 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.47 (04.11.2022) -1.63 %
Thermo Fisher Scientific Inc.
TMO 495.55 (04.11.2022) 1.77 %
Tilray, Inc.
TLRY 3.81 (04.11.2022) -0.26 %
UnitedHealth Group, Inc.
UNH 538.17 (04.11.2022) -1.00 %
Veeva Systems Inc.
VEEV 166.81 (04.11.2022) -0.20 %
Zomedica Corp.
ZOM 0.2245 (04.11.2022) -2.01 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.7051 (04.11.2022) -2.07 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.